GYREGYRE THERAPEUTICS, INC.

Nasdaq www.gyretx.com


$ 11.63 $ 0.87 (7.99 %)    

Monday, 19-Aug-2024 15:59:06 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 11.76
$ 10.94
$ 10.83 x 100
-- x --
$ 10.94 - $ 11.81
$ 0.32 - $ 30.40
26,574
na
1.23B
$ 5.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-27-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-04-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 02-20-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 03-08-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 03-19-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-03-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 gyre-pharmaceuticals-receives-ind-approval-from-center-for-drug-evaluation-of-chinas-nmpa-to-evaluate-f230-for-the-treatment-of-pulmonary-arterial-hypertension

Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibr...

 gyre-therapeutics-q1-eps-003-same-yoy-sales-2717m-up-from-2493m-yoy

Gyre Therapeutics (NASDAQ:GYRE) reported quarterly earnings of $0.03 per share. This is unchanged from the same period last yea...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 enliven-therapeutics-alpine-immune-sciences-janux-therapeutics-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NA...

 why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

 why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

 carvana-posts-q4-results-joins-legalzoomcom-comfort-systems-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.

 applied-materials-posts-upbeat-earnings-joins-texas-roadhouse-vulcan-materials-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

 why-blackberry-shares-are-trading-lower-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION